Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bayer, Onyx cancer treatment Nexavar falls short of main goal in late-stage lung cancer study
Bayer, Onyx cancer treatment Nexavar falls short of main goal in late-stage lung cancer study
Bayer, Onyx cancer treatment Nexavar falls short of main goal in late-stage lung cancer study
Submitted by
admin
on May 22, 2012 - 9:42am
Source:
Yahoo/AP
News Tags:
Bayer
Onyx
Nexavar
lung cancer
Headline:
Bayer, Onyx cancer treatment Nexavar falls short of main goal in late-stage lung cancer study
Do Not Allow Advertisers to Use My Personal information
